Yokota Masaki, Ouchi Jiro, Miyagi Yuzuru, Matsuo Susumu, Uchimura Koutaro, Sumii Toshihiko, Iguchi Haruo, Funakoshi Akihiro
Dept. of Gastroenterology, National Kyushu Cancer Center.
Gan To Kagaku Ryoho. 2002 Feb;29(2):293-5.
A patient with advanced gastric cancer complicated with liver and lymph node metastases was successfully treated with a novel oral anticancer drug, TS-1, TS-1 was administered at a dose of 100 mg/day. One course consisted of consecutive administration of TS-1 for 28 days and withdrawal for 14 days. At the end of 3 courses a partial response of the liver metastases was achieved. Although the patient has had complications with ascites collection due to hypoalbuminemia, he has been well without regrowth of any metastases for over 8 months.
一名晚期胃癌合并肝和淋巴结转移的患者成功接受了一种新型口服抗癌药物TS-1的治疗，TS-1的给药剂量为100毫克/天。一个疗程包括连续服用TS-1 28天，然后停药14天。在3个疗程结束时，肝转移灶出现部分缓解。尽管患者因低白蛋白血症出现腹水收集并发症，但他情况良好，8个多月来任何转移灶均未复发。
